Compare NIKI & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NIKI | ADIL |
|---|---|---|
| Founded | N/A | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 7.3M |
| IPO Year | 2018 | 2017 |
| Metric | NIKI | ADIL |
|---|---|---|
| Price | $7.82 | $5.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | 24.2K | ★ 65.1K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.80 | $0.13 |
| 52 Week High | $10.39 | $5.17 |
| Indicator | NIKI | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 73.77 |
| Support Level | N/A | $1.63 |
| Resistance Level | $10.00 | N/A |
| Average True Range (ATR) | 0.83 | 0.58 |
| MACD | -0.17 | 0.12 |
| Stochastic Oscillator | 4.27 | 96.21 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.